BĆBranka Golubić Ćepulić

Branka Golubić Ćepulić

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Branka Golubić Ćepulić has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Next Generation Sequencing in Defining the Composition of Bacterial Microbiota of Donated Human Milk

    by Jurjana Novoselac, Andreja Leboš Pavunc, Nina Čuljak, Davor Ježek, Zrinka Bošnjak, Branka Golubić Ćepulić

    Novoselac J, et al. Pediatr Gastroenterol Hepatol Nutr. 2025 Nov;28(6):381-392. https://doi.org/10.5223/pghn.2025.28.6.381

  • The effect of prophylactic extracorporeal photopheresis on cardiac allograft vasculopathy during the first post-transplant year in de novo heart transplant recipients: ECP-OCT2019 study design

    by Mia Dubravčić Došen, Hrvoje Jurin, Marijan Pašalić, Branka Golubić Ćepulić, Ines Bojanić, Sanja Mazić, Dora Fabijanović, Nina Jakuš, Ivo Planinc, Jure Samardžić, et al.

  • Open Access

    The impact of cryoprotectant exposure time on post-thaw viability of autologous and allogeneic hematopoietic stem cells and leukocyte subpopulations

    by Vladimira Rimac, Ines Bojanić, Sanja Dabelić, Branka Golubić Ćepulić

    Although the use of cryoprotectant dimethyl sulfoxide (DMSO) is the gold standard in cryopreservation of hematopoietic stem cells, it is well known that it has a negative effect on cell viability. The aim of this prospective study was to examine how the length of post-thaw exposure to DMSO affects the cell viability and stability of peripheral blood stem cell (PBSC) samples. Additionally, the effects of donor type and pre-cryopreservation storage time on post-thaw viability during the stability study were evaluated. In 30 autologous and 30 allogeneic PBSC samples viable CD34+, CD14+, CD19+, CD16+/56+, and CD3+ cells were determined immediately after thawing, and one-and three-hours post-thaw. Analysis of the absolute count of viable cells in thawed samples showed a significant difference between all measurement points for CD34+ ( p < 0.001), CD14+ ( p < 0.001), and CD19+ cells ( p < 0.001). No significant differences were observed for post-thaw stability of allogeneic samples analysed between products stored before cryopreservation ≥ 24 hours (N = 20), and those stored < 24 hours (N = 10), except for viable CD3+/CD4+ cells after three hours post-thaw ( p = 0.028). In conclusion, DMSO had different effects on leukocyte subpopulations in cryopre-served PBSC samples. The type of donors and the length of storage before cryopreservation did not affect the post-thaw stability of cryopreserved PBSC samples.


  • Open Access

    The effect of anticoagulation therapy on perioperative bleeding risk in patients undergoing heart transplantation

    by Petra Mjehović, Mia Dubravčić Došen, Marijan Pašalić, Maja Čikeš, Dora Fabijanović, Nina Jakuš, Hrvoje Jurin, Daniel Lovrić, Ivo Planinc, Jure Samardžić, et al.

  • Desensitization procedures in heart transplant recipients: a case series

    by Mia Dubravčić Došen, Petra Mjehović, Dubravka Šipuš, Maja Čikeš, Dora Fabijanović, Nina Jakuš, Hrvoje Jurin, Daniel Lovrić, Marijan Pašalić, Ivo Planinc, et al.

  • Open Access

    Impact of COVID-19 pandemic on collection of allogeneic hematopoietic stem cells

    by Klinički Zavod, Ivona Horvat, Ines Bojanić, Sanja Mazić, Nadira Duraković, Radovan Vrḫovac, Branka Golubić Ćepulić

  • Changes in the incidence of transfusion reactions in hematological patients over the past 30 years

    by Ines Bojanić, Marija Lukić, Fini Plenković, Mirela Raos, Marta Medenjak, Branka Golubic Ćepulić

    Background: Patients with hematological diseases are polytransfused and often immunocompromised, therefore susceptible to transfusion reactions (TR). This study aims to document the incidence of TRs in adult hematological patients and assess the effect of changes in the production of blood components and transfusion practice on their occurrence.Study design and methods: Retrospective observational analysis of TRs reported from 1993 to 2019 was performed. For the analysis of the effect of changes on the incidence of TRs, the evaluated time was divided into two periods: the 1st period before the introduction of changes in production, when leukoreduced blood components were used only selectively, and the 2nd period, when semi‐automated method of production and universal leukoreduction was introduced.Results: The decrease in the incidence of TRs was observed for both red blood cell (RBC) and platelet concentrate (PC) transfusions in the 2nd period. Since platelet additive solution has been used, a further decrease in the incidence was reported. The decrease in incidence was also observed for delayed hemolytic/serological transfusion reactions and for transfusion‐transmitted bacterial infections. Four cases of incorrect blood transfusions were uniquely related to the hematological patients, caused by antigen loss and transfusion ordering after ABO‐incompatible hematopoietic stem cell transplantation.Discussion: Our results provided evidence that the introduction of tools offered by modern transfusion medicine: universal leukodepletion, plasma replacement with additive solutions, sensitive laboratory techniques, prophylactic antigen matching policy, informatization, and automatization, decreased the incidence of TRs and improved transfusion safety.


  • Open Access

    110 OPENING OF THE FIRST HUMAN MILK BANK IN CROATIA

    by Branka Golubić Ćepulić, Anita Pavičić Bošnjak, Ivana Leskovar, Jurjana Novoselac, Koraljka Gojčeta, Vladimira Rimac, Ines Bojanić, Sanja Mazić

    Objective Foundation project for the first human milk banks (HMB) in Croatia was launched in 2017 as the result of a collaboration between the Ministry of Health, University Hospital Centre (UHC) Zagreb, UNICEF and the Croatian Association of Breastfeeding Support Groups. The HMB was opened in UHC Zagreb on November 15, 2019as a part of the Croatian Tissue and Cell Bank, a division of the Department of Transfusion Medicine and Transplantation Biology. The specific technical side is based on the PATH standards and Guide to the quality and safety of tissues and cells for human application, Council of Europe. On January 10, 2020, HMB passed a Competent Authority (CA) inspection, conducted in accordance with the requirements of national tissue legislation that has been adapted to EU Directive 2004/23/EC on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. The specific technical part is based on the PATH standards and Guide to the quality and safety of tissues and cells for human application, Council of Europe. The aim of this study was to review the very first experience in human milk banking in Croatia. Methods We retrospectively analysed the data of the first 28 human milk donors. Results From the opening to mid-February, 135 women showed interest in donating human milk, of which 28 became donors. In February 2020, we had 24 still active donors. Four women stopped donating, with a median donation period of 2 months. All donors were tested for blood borne viruses by serology and NAT and were negative. In total, we received 79 L of donated human milk.We started pasteurizing the milk after obtaining a license. Of the 30 controlled pre-pasteurization milk pools, 10% was over the allowed microbial contamination. Microbiological controls were performed for each pasteurization cycle. They were all sterile. The nutritional values of milk were all within the expected range. Conclusions Human milk is recognised as the optimal feeding for all newborn infants. When mothers’ own milk is not available, donor human milk provided by HMB is the second-best choice, especially for premature or sick infants. The opening of the HMB in Croatia is highly important in helping to provide the best possible medical care for prematurely born babies and infants with a serious medical condition when they cannot receive their mother’s milk.

  • Open Access

    Evaluation of antibody screening and identification pre-transfusion tests using DG Gel cards

    by Mirela Raos, Jurjana Novoselac, Iva Lucija Burnać, Marija Lukić, Ivana Leskovar, Branka Golubić Ćepulić


  • Comparative Analysis of Biological and Functional Properties of Bone Marrow Mesenchymal Stromal Cells Expanded in Media with Different Platelet Lysate Content

    by Marijana Skific, Mirna Golemovic, Kristina Crkvenac-Gornik, Radovan Vrhovac, Branka Golubic Cepulic

    Due to their ability to induce immunological tolerance in the recipient, mesenchymal stromal cells (MSCs) have been utilized in the treatment of various hematological and immune- and inflammation-mediated diseases. The clinical application of MSCs implies prior in vitro expansion that usually includes the use of fetal bovine serum (FBS). The present study evaluated the effect of different platelet lysate (PL) media content on the biological properties of MSCs. MSCs were isolated from the bone marrow of 13 healthy individuals and subsequently expanded in three different culture conditions (10% PL, 5% PL, 10% FBS) during 4 passages. The cells cultured in different conditions had comparable immunophenotype, clonogenic potential, and differentiation capacity. However, MSC growth was significantly enhanced in the presence of PL. Cultures supplemented with 10% PL had a higher number of cumulative population doublings in all passages when compared to the 5% PL condition (p < 0.03). Such a difference was also observed when 10% PL and 10% FBS conditions were compared (p < 0.005). A statistically significant difference in population doubling time was determined only between the 10% PL and 10% FBS conditions (p < 0.005). Furthermore, MSCs cultured in 10% PL were able to cause a 66.9% reduction of mitogen-induced lymphocyte proliferation. Three chromosome aberrations were detected in PL conditions. Since two changes occurred in the same do nor, it is possible they were donor dependent rather than caused by the culture condition. These findings demonstrate that a 10% PL condition enables a higher yield of MSCs within a shorter time without altering MSC properties, and should be favored over the 5% PL condition.